ATXA Therapeutics is a clinical-stage pharmaceutical company committed to the advancement of innovative treatments for cardiopulmonary diseases. Self-described as focusing on developing novel antagonists of the Thromboxane Receptor (TP).
peer of
competitor of
Metrics
marketPRIVATE
msh_idCOM:ATXATHERAPEUTICS
localeie
websitehttps://www.atxatherapeutics.com/
source_ref0dc3d85e-f96b-4562-bf71-0d2a8ac38f63
products_or_servicesDevelopment of innovative treatments for cardiopulmonary diseases, focusing on Thromboxane Receptor antagonists.
Ireland